Details werden geladen...
Experimental Drug May Offer a 'Functional Cure' for Some People with Chronic Hepatitis B
Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.
Ähnliche Seiten
Experimental hepatitis B drug may offer 'functional cure' for some patients
https://www.ctvnews.ca/health/article/experimental-hepatitis-b-drug-may-offer-functional-cure-for-some-patients/
Experimental hepatitis B drug may offer ‘functional cure’ for some patients - The Boston Globe
https://www.bostonglobe.com/2026/05/28/business/experimental-hepatitis-b-drug/
GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gsks-chronic-hepatitis-b-drug-helps-one-in-five-achieve-functional-cure-in-key-studies/articleshow/131366419.cms
Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show
https://www.statnews.com/2026/05/28/hepatitis-b-treatment-gsk-clinical-trials/
GSK, Ionis’ hepatitis B functional cure effectively eliminates virus in nearly 20% of patients - BioSpace
https://www.biospace.com/drug-development/gsk-ionis-hepatitis-b-functional-cure-effectively-eliminates-virus-in-nearly-20-of-patients